Notably, SPOP not only can be functionalized as a tumor suppressor by targeting androgen receptor for degradation, but also as an oncoprotein in renal cancer, resulting in activation of androgen receptor driven pathways [38]. This evidence concerns the gene SPOP and neoplasm.